Cargando…
Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia
BACKGROUND AND OBJECTIVES: Laryngeal dystonia (LD) is isolated task-specific focal dystonia selectively impairing speech production. The first choice of LD treatment is botulinum neurotoxin (BoNT) injections into the affected laryngeal muscles. However, whether BoNT has a lasting therapeutic effect...
Autores principales: | O'Flynn, Lena C., Simonyan, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536744/ https://www.ncbi.nlm.nih.gov/pubmed/35764404 http://dx.doi.org/10.1212/WNL.0000000000200850 |
Ejemplares similares
-
DystoniaBoTXNet: Novel Neural Network Biomarker of Botulinum Toxin Efficacy in Isolated Dystonia
por: Yao, Dongren, et al.
Publicado: (2023) -
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia
por: Yeung, Winnie, et al.
Publicado: (2022) -
Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia
por: Bhidayasiri, Roongroj, et al.
Publicado: (2022) -
Laryngeal dystonia: case report and treatment with botulinum toxin
por: Santos, Victor José Barbosa, et al.
Publicado: (2015) -
Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020)